Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heather N Andrews

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Breast Cancer Research and Treatment|September 21, 2005
Celecoxib inhibits urokinase-type plasminogen activator (uPA) production in MDA-MB-231 breast cancer cellsHeather N Andrews, Golerah Habibi, Jill E Kucab, et al.
Psychosomatic Medicine|November 30, 2006
Temporal factors alter effects of social housing conditions on responses to chemotherapy and hormone levels in a Shionogi mammary tumor modelLeslie R Kerr, Heather N Andrews, Karen S Strange, et al.
Translational Oncogenomics|May 7, 2013
Urokinase-type Plasminogen Activator (uPA) is Inhibited with QLT0267 a Small Molecule Targeting Integrin-linked Kinase (ILK)Nancy Dos Santos, Golareh Habibi, Michelle Wang, et al.
The Journal of Biological Chemistry|May 16, 2002
BRCA1 regulates the interferon gamma-mediated apoptotic responseHeather N Andrews, Paul B Mullan, Stewart McWilliams, et al.
Cancer Research|June 19, 2004
BRCA1 interacts with and is required for paclitaxel-induced activation of mitogen-activated protein kinase kinase kinase 3Paula M Gilmore, Nuala McCabe, Jennifer E Quinn, et al.
Cancer Research|January 20, 2004
Expression of the insulin-like growth factor I receptor and urokinase plasminogen activator in breast cancer is associated with poor survival: potential for intervention with 17-allylamino geldanamycinTorsten O Nielsen, Heather N Andrews, Maggie Cheang, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Breast Cancer Research and Treatment|September 21, 2005
Celecoxib inhibits urokinase-type plasminogen activator (uPA) production in MDA-MB-231 breast cancer cellsHeather N Andrews, Golerah Habibi, Jill E Kucab, et al.
Psychosomatic Medicine|November 30, 2006
Temporal factors alter effects of social housing conditions on responses to chemotherapy and hormone levels in a Shionogi mammary tumor modelLeslie R Kerr, Heather N Andrews, Karen S Strange, et al.
Translational Oncogenomics|May 7, 2013
Urokinase-type Plasminogen Activator (uPA) is Inhibited with QLT0267 a Small Molecule Targeting Integrin-linked Kinase (ILK)Nancy Dos Santos, Golareh Habibi, Michelle Wang, et al.
The Journal of Biological Chemistry|May 16, 2002
BRCA1 regulates the interferon gamma-mediated apoptotic responseHeather N Andrews, Paul B Mullan, Stewart McWilliams, et al.
Cancer Research|June 19, 2004
BRCA1 interacts with and is required for paclitaxel-induced activation of mitogen-activated protein kinase kinase kinase 3Paula M Gilmore, Nuala McCabe, Jennifer E Quinn, et al.
Cancer Research|January 20, 2004
Expression of the insulin-like growth factor I receptor and urokinase plasminogen activator in breast cancer is associated with poor survival: potential for intervention with 17-allylamino geldanamycinTorsten O Nielsen, Heather N Andrews, Maggie Cheang, et al.
Pageof 1